P
Prelude Therapeutics Incorporated
PRLD · NASDAQ · Healthcare · 316M
Price · close
$6.63
+2.00% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
7.4×
Enterprise value / EBITDAEV/EBITDA
-3.6×
Free cash flow yieldFCF yield
-11.0%
Return on equityROE
-145.0%
Operating margin
-861.3%
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.